dom

Anyone recommend buying Wirecard shares??

NO

I'm not going to argue with a pro!  However, if I have a few K's to "spend" and see that for example, Wirecard shares have tumbled due to their hiding their finances from the authorities, but that they are otherwise an innovative fintech, can I not make a good investment now since the chances of the share price increasing by at least 30€ in the next few weeks look promising?    

Trade Republic is not as good as Revolut!

  Balti, let me help you out here:   Dom, some reputable guy on the British Toytown Germany forum, thinks that NYU Professors of Medicine who are highly fixated on rectums is on the wrong track.   Better? 

  I'm sure we'll hear about REctally Administered UV-Radiation, or REAR, from Balti very soon... probably pre-published, i.e. straight from the horse's arse! 

well said!   The funeral of my cousin will be streamed today on obitus.com...4 weeks after her death to covid. It's too weird to be partaking online.   I hope the UK Government gets to grips with this pandemic asap. Am really worried that UK based family are still at too high a risk. 

  WTF are you going on about? I simply mean there's no point in circulating articles on studies that have not yet been refereed! ...and many reputable institutions publish articles which I'm afraid make no significant impact. You can start taking zinc sulfate daily if you want...just don't overdose yourself!  

  Oh dear, Baticus! Is that your answer as to why unrefereed articles should be circulated by you?   If NYU GMS is 4th in the US, they may become number 1 if they publish on injecting disinfectant into the lungs of patients!  It is probably more intellectual than to pick up whatever they first find on the shelf in their garden shed !  

Zinc? WTF should zinc actually do against corona? Zinc ions are pretty unspecific. We should put our hopes on antibodies, vaccines and ACE2 inhibitors.  

  I would not bother reading unrefereed preprints!   What is an unrefereed preprint? Before formal publication in a scholarly journal, scientific and medical articles are traditionally certified by “peer review.” In this process, the journal’s editors take advice from various experts—called “referees”—who have assessed the paper and may identify weaknesses in its assumptions, methods, and conclusions. Typically a journal will only publish an article once the editors are satisfied that the authors have addressed referees’ concerns and that the data presented support the conclusions drawn in the paper. Because this process can be lengthy, authors use the medRxiv service to make their manuscripts available as “preprints” before certification by peer review, allowing other scientists to see, discuss, and comment on the findings immediately. Readers should therefore be aware that articles on medRxiv have not been finalized by authors, might contain errors, and report information that has not yet been accepted or endorsed in any way by the scientific or medical community. We also urge journalists and other individuals who report on medical research to the general public to consider this when discussing work that appears on medRxiv preprints and emphasize it has yet to be evaluated by the medical community and the information presented may be erroneous.

 

  only picture I could find of the mortuary

  "According to a recent study (May 1st 2020) you have a 30% chance of dying if you end up in a British hospital with COVID-19. That’s about the same overall mortality rate as for Ebola in 2014 in West Africa."   https://www.sciencemag.org/news/2020/05/finally-virus-got-me-scientist-who-fought-ebola-and-hiv-reflects-facing-death-covid-19#